Max Delbrück Center

Mithryon

Other

Berlin, Germany
12 profile visits

About

building an AI-enabled platform to identify novel tumor degraders and prioritise opportunities for targeted protein degradation and molecular glue therapeutics.

Disease Area

Cancer

Biomedical Research, Medicine, Human Health

Drug Target DiscoveryDiagnostics

Technology

Data science, AI / Machine learningBioengineering(Single-cell) multi-omicsPersonalized disease models

Representatives

(Pre-)Founder

Mithryon